LLC Insight Holdings Group Buys Shares of Hinge Health (HNGE)
LLC Insight Holdings Group purchases 533,228 shares of Hinge Health on June 24, 2026.
Key Points
- LLC Insight Holdings Group bought 533,228 shares of Hinge Health, Inc. on June 24, 2026.
- Hinge Health, Inc. trades at $70.38 with a market cap of $5.33 billion and a forward P/E of 20.6.
- Analysts maintain a 'buy' consensus on Hinge Health, with a mean price target of $79.73.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
LLC Insight Holdings Group made a significant move on June 24, 2026, purchasing 533,228 shares of Hinge Health, Inc. (NYSE: HNGE). This transaction was not planned and reflects an addition to their holdings in the company.
Other Institutional Activity in Hinge Health
Insight Holdings Group, LLC maintained its position with 9,375,164 shares valued at about $361.5 million. Meanwhile, Deer Management Co. LLC opened a new position with 2,633,707 shares worth $101.6 million. Bit Capital GmbH reduced its holdings by 1,006,304 shares, ending with 2,309,797 shares valued at $89.1 million, marking a 30.3% decrease. RTW Investments, LP significantly increased its stake by 1,576,500 shares, now holding 1,930,000 shares valued at $74.4 million, a 446% increase.
Hinge Health, Inc. Stock Down 19.2%
Shares of NYSE:HNGE traded near $70.38 on Thursday. Hinge Health has a market cap of approximately $5.33 billion, with a forward P/E ratio of 20.6 and a beta of 1.0. The stock's 52-week range is between $30.08 and $71.43, with a 50-day moving average of $52.90 and a 200-day moving average of $47.85. The company maintains a current ratio of 1.30 and a quick ratio of 1.04, with a debt-to-equity ratio of 2.24.
$HNGE stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Hinge Health reported revenues of $646.3 million, reflecting a growth of 47.2%. Despite this, the company has a negative net margin of 78.95% and a return on equity of -136.0%. The next earnings report is expected on August 4, 2026.
Analysts Set New Price Targets
On June 24, 2026, Wells Fargo maintained a 'buy' rating on Hinge Health with a price target of $90. Baird, on June 17, kept a 'hold' rating with a $65 target. Raymond James and Canaccord Genuity both maintained 'buy' ratings with targets of $80 and $76, respectively. The consensus among 15 analysts is a 'buy' recommendation, with a mean target price of $79.73.
About Hinge Health
Hinge Health, Inc. is a healthcare company based in San Francisco, California, specializing in the development of technology-driven care solutions for musculoskeletal issues, such as acute injuries, chronic pain, and post-surgical rehabilitation. The company uses AI-powered motion tracking and proprietary wearable devices to offer personalized care, primarily targeting self-insured employers. Founded in 2012, Hinge Health is led by CEO Daniel A. Perez and employs over 1,400 people.
Bottom Line
Investors are keeping an eye on Hinge Health, Inc. as LLC Insight Holdings Group increases its stake. The company's innovative approach to musculoskeletal care and solid revenue growth make it a notable player in the healthcare sector. However, it's important to remember that this insider transaction reflects the position as of June 24, 2026, and may not indicate future moves.
Get Hinge Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HNGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.